Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 6, 2009, Pages 1086-1095

  De Filippis, Daniele ^a,b   D'Amico, Alessandra ^a,b   Cinelli, Maria Pia ^b   Esposito, Giuseppe ^c   Di Marzo, Vincenzo ^a,d   Iuvone, Teresa ^a,b  

^a Endocannabinoid Research Group   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR   (Italy)

Author keywords

Adelmidrol; Inflammation; Mast cells; Palmitoylethanolamide

Indexed keywords

ADELMIDROL; CARRAGEENAN; DICARBOXYLIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRITE; PALMIDROL; PALMITIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE;

ANIMAL; ARTICLE; CELL COUNT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC DISEASE; DOSE RESPONSE; DRUG EFFECT; GRANULOMA; INFLAMMATION; LEUKOCYTE; MALE; MAST CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; WESTERN BLOTTING; WISTAR RAT; CHEMICALLY INDUCED; DRUG EFFECTS; NEOVASCULARIZATION, PATHOLOGIC;

ANIMALS; BLOTTING, WESTERN; CARRAGEENAN; CELL COUNT; CHRONIC DISEASE; DICARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOMA; INFLAMMATION; LEUKOCYTES; MALE; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PALMITIC ACIDS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; ENDOCANNABINOIDS; ETHANOLAMINES;

RATTUS;

EID: 67649866293     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00353.x     Document Type: Article

References (59)

1. th ed. New York : McGraw-Hill 1999. pp. 2733 4.
2. Pulvirenti N, Nasca MR, Micali G. Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study. Acta Dermatovenerol Croat. 2007 15 : 80 3.
3. Abramo F, Salluzzi D, Leotta R, Noli C, Auxilia S, Mantis P, Lloyd D. Mast cell morphometry of cutaneous wounds treated with an autacoid gel: a placebo-controlled study. Vet Dermatol. 2004 15 : 39 39.
4. Miolo A, Re G, Barbero R, Giorgi M, Leotta R, Auxilia S, Noli C, Abramo F. Aliamides modulate skin mast cell degran-ulation in dogs and cats. J Vet Pharmacol Ther. 2006 29 : 204 5.
5. Aloe L, Leon A, Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions. 1993 39 : 146 9.
6. Levi-Montalcini R, Skaper SD, Dal Toso R, Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 1996 19 : 514 20.
7. Jack DB. Aliamides: a new approach to the treatment of inflammation. Drug News Perspect. 1996 9 : 93 8.
8. Schmid HH, Schmid PC, Natarajan V. N-acylated glycerophospholipids and their derivatives. Prog Lipid Res. 1990 29 : 1 43. (Pubitemid 120036504)
9. Schmid HH, Berdyshev EV. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function. Prostaglandins Leukot Essent Fatty Acids. 2002 66 : 363 76.
10. De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V. Effect on cancer cell proliferation of palmi-toylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanil-loid signalling systems. Fundam Clin Pharmacol. 2002 16 : 297 302. (Pubitemid 35205340)
11. Lambert DM, Di Marzo V. The palmi-toylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem. 1999 6 : 757 73.
12. Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ. "Entourage" effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol. 2002 3 : 452 8.
13. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Pomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmi-toylethanolamide. Mol Pharmacol. 2005 67 : 15 9.
14. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. The orphan receptor GPR55 is a novel cannabi-noid receptor. Br J Pharmacol. 2007 152 : 1092 101.
15. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 1998 394 : 277 81.
16. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol. 2002 135 : 181 7.
17. Di Marzo V, Melck D, De Petrocellis L, Bisogno T. Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins Other Lipid Mediat. 2000 61 : 43 61. (Pubitemid 30216488)
18. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmi-toylethanolamide. Mol Pharmacol. 2005 67 : 15 9.
19. Wise LE, Cannavacciulo R, Cravatt BF, Marun BF, Lichtman AH. Evaluation of fatty acid amides in the car-rageenan-induced paw edema model. Neuropharmacology. 2008 54 : 181 8.
20. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 1995 92 : 3376 80.
21. Granberg M, Fowler CJ, Jacobsson SO. Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anan-damide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF release from rat RBL-2H3 basophilic leukaemia cells. Naunyn Schmiedebergs Arch Pharmacol. 2001 364 : 66 73. (Pubitemid 32646343)
22. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol. 1996 300 : 227 36.
23. Scarampella F, Abramo F, Noli C. Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comi-cronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study. Vet Dermatol. 2001 12 : 29 39. (Pubitemid 33686131)
24. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA. 1986 83 : 4464 8.
25. Iuvone T, Den Bossche RV, D'Acquisto F, Carnuccio R, Herman AG. Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol. 1999 128 : 700 4.
26. Crivellato E, Ribatti D. Involvement of mast cells in angiogenesis and chronic inflammation. Curr Drug Targets Inflamm Allergy. 2005 4 : 9 11. (Pubitemid 40584848)
27. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007 217 : 304 28.
28. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation. 2006 13 : 347 56.
29. Russo A, Russo G, Peticca M, Pietropaolo C, Di Rosa M, Iuvone T. Inhibition of granuloma-associated angio-genesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol. 2005 145 : 24 33. (Pubitemid 40675545)
30. Colville-Nash PR, Alam CA, Appleton I, Brown JR, Seed MP, Willoughby DA. The pharmacological modulation of angiogene-sis in chronic granulomatous inflammation. J Pharmacol Exp Ther. 1995 274 : 1463 72.
31. De Filippis D, Russo A, De Stefano D, Maiuri MC, Esposito G, Cinelli MP, Pietropaolo C, carniccio R, Russo G, Iuvone T. Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation. J Mol Med. 2007 85 : 635 45.
32. 2 up-regulation in women affected by endometrial inflammation. J Cell Mol Med. 2008 12 : 661 70.
33. Lambert DM, DiPaolo FG, Sonveaux P, Kanyonyo M, Govaerts SJ, Hermans E, Bueb J, Delzenne NM, Tschirhart EJ. Analogues and homologues of N-palmi-toylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors. Biochim Biophys Acta. 1999 1440 : 266 74.
34. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Effects of homo-logues and analogues of palmi-toylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol. 2001 133 : 1263 75.
35. Vandevoorde S, Lambert DM, Smart D, Jonsson KO, Fowler CJ. N-Morpholino-and N-diethyl-analogues of palmi-toylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. Bioorg Med Chem. 2003 11 : 817 25.
36. Iuvone T, Van Osselaer N, D'Acquisto F, Carnuccio R, Herman AG. Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat. Br J Pharmacol. 1997 121 : 1637 44.
37. Maiuri MC, Tajana G, Iuvone T, De Stefano D, Mele G, Ribecco MT, Cinelli M P, Romano MF, Turco MC, Carniccio R. Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol. 2004 165 : 115 26.
38. Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, Iuvone T. The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J Biol Chem. 2002 277 : 50348 54.
39. Esposito G, De Filippis D, Steardo L, Scuderi C, Savani C, Cuomo V, Iuvone T. CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci Lett. 2006 404 : 342 6.
40. Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett. 2006 399 : 91 5.
41. Esposito G, Scuderi C, Savani C, Steardo L Jr., De Filippis D, Cottone P, Iuvone T, Cuomo V, Steardo L. Cannabidiol in vivo blunts beta-amyloid-induced neuroinflam-mation by suppressing IL-1beta and iNOS expression. Br J Pharmacol. 2007 151 : 1272 9.
42. Van Der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, Micale V, Steardo L, Grago F, Iuvone T, Di Marzo V. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci. 2006 63 : 1410 24.
43. Colakogullari M, Ulukaya E, Yilmaztepe A, Ocakoglu G, Yilmaz M, Karadag M, Tokullugil A. Higher serum nitrate levels are associated with poor survival in lung cancer patients. Clin Biochem. 2006 39 : 898 903. (Pubitemid 44344692)
44. Vila V, Martinez-Sales V, Almenar L, Lazaro IS, Villa P, Reganon E. Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients. Int J Cardiol. 2008 130 : 276 7.
45. Kinet JP. The essential role of mast cells in orchestrating inflammation. Immunol Rev. 2007 217 : 5 7.
46. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007 217 : 65 78. (Pubitemid 46718152)
47. Eady RA, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol. 1979 100 : 623 33.
48. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol. 1997 61 : 233 45.
49. Caughey GH. Mast cell tryptases and chy-mases in inflammation and host defense. Immunol Rev. 2007 217 : 141 54.
50. Paquet P, Nusgens BV, Pierard GE, Lapiere CM. Gelatinases in drug-induced toxic epidermal necrolysis. Eur J Clin Invest. 1998 28 : 528 32.
51. Jackson CJ, Nguyen M. Human microvas-cular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol. 1997 29 : 1167 77.
52. Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, Henz BM, Welker P. Mast cells and vasculature in atopic dermatitis - potential stimulus of neoan-giogenesis. Allergy. 2005 60 : 90 7.
53. Purwar R, Kraus M, Werfel T, Wittmann M. Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. J Invest Dermatol. 2008 128 : 59 66. (Pubitemid 350249368)
54. Di Girolamo N, Indoh I, Jackson N, Wakefield D, McNeil HP, Yan W, Geczy C, Arm JP, Tedla N. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J Immunol. 2006 177 : 2638 50.
55. Rodriguez-Pla A, Bosch-Gil JA, Rossello-Urgell J, Huguet-Redecilla P, Stone JH, Vilardell-Tarres M. Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling. Circulation. 2005 112 : 264 9.
56. Mantis P, Lloyd DH, Pfeiffer D, Stevens K, Auxilia S, Noli C, Abramo F, Miolo A. Assessment of the effect of an aliamide-containing topical gel by evaluation of the reduction of wound volume measured by high resolution ultrasound biomicroscopy. Wounds. 2007 19 : 113 9.
57. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005 15 : 599 607. (Pubitemid 41619424)
58. Weller K, Foitzik K, Paus R, Syska W, Maurer M. Mast cells are required for normal wound healing of skin wound in mice. FASEB J. 2006 20 : 2366 8.
59. de Mora F, Puigdemont A, Torres R. The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems. Br J Dermatol. 2006 155 : 1109 23.